Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2023 2
2024 1
2025 2
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.
Rial-Crestelo D, Llenas-García J, Hidalgo-Tenorio C, Troya García J, Galindo Puerto MJ, Alemán Valls MR, Torralba González de Suso M, Buzón L, Díaz de Santiago A, Rodríguez A, Calzado Isbert S, Aguilera García M, Morano Amado LE, Vinuesa García D, Bernal Morell E, Martínez Álvarez RM, Cabello-Clotet N, Fernández A, Montero Hernández MDC, Díez Romero C, Calderón Hernaiz R, Pérez Martínez D, Gisbert Pérez L, Arenas García V, Escrich C, Fariñas Álvarez MC, Lucas Dato A, Losa García JE, Pernas Pardavila H, Gainzarain JC, Estébanez M, Barragán Gallo P, Clavero Olmos M, Egido Murciano MV, Benéitez OLF, Pedrero-Tomé R, Cabello-Úbeda A, Martín-Carbonero L; RELATIVITY studygroup. Rial-Crestelo D, et al. Among authors: lucas dato a. Open Forum Infect Dis. 2026 Jul 7;13(7):ofag426. doi: 10.1093/ofid/ofag426. eCollection 2026 Jul. Open Forum Infect Dis. 2026. PMID: 42460401 Free PMC article.
Clinical outcomes of long-acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real-world data from the Spanish RELATIVITY cohort.
Troya J, Montes ML, Galindo MJ, Santiago AD, Lagarde M, Rodríguez D, Rodríguez A, Crussels MJ, Torralba M, Hidalgo C, Fanjul F, Soler JF, Gisbert L, Díez C, Pérez D, Romero A, Ferreira EM, Cabo R, Rúiz-Alonso N, Escrich C, Sepúlveda MA, Padilla S, Corte JJ, Pedrero-Tomé R; RELATIVITY Group; Buzón L. Troya J, et al. HIV Med. 2026 Jan;27(1):58-73. doi: 10.1111/hiv.70114. Epub 2025 Oct 21. HIV Med. 2026. PMID: 41118425
Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort.
Llenas-García J, Arcos Rueda MDM, Calderón Hernaiz R, Pedrero Tomé R, Bisbal Pardo O, Matarranz M, Torralba M, Galindo Puerto MJ, Rodríguez A, Peñaranda Vera M, Sanjoaquín Conde I, de la Fuente Moral S, Cabello-Úbeda A, Navarro San Francisco C, Antelo Cuéllar K, Pedrosa Aragón M, Aguilera García M, Tiraboschi J, Martínez Álvarez RM, Vivancos MJ, Montero Hernández C, Bernal Morell E, Cabello-Clotet N, Morano Amado LE, Gisbert Pérez L, Sepúlveda MA, Alemán Valls MR, Sánchez Guirao AJ, Fanciulli C, Escrig C, Ferreira Pasos EM, Lucas-Dato A, García Torras S, Hidalgo Tenorio C, Estébanez M, Muelas-Fernandez M, Losa García JE, Cerezales Calviño A, Pino Díaz ME, Martínez Montes C, Arenas García V, Arnaiz de Las Revillas F, Pernas Pardavila H, Padilla S, Garcinuño Jiménez MÁ, Alonso Alonso L, Ramos Vicente N, Barragán Gallo PN, Cabo Magadan R, Del Álamo M, Egido Murciano MV, Juárez Toquero A, Romero Palacios A, Clavero Olmos M, García Navarro MDM, Sanz J, Gainzarain JC, Milian Sanz M, de la Calle B, Ferrero Benéitez OL, Troya J, Buzón-Martín L; RELATIVITY Group. Llenas-García J, et al. Among authors: lucas dato a. J Int AIDS Soc. 2026 Apr;29(4):e70106. doi: 10.1002/jia2.70106. J Int AIDS Soc. 2026. PMID: 42011965 Free PMC article.
Cutaneous lesions in travelers, migrants and VFRs, +Redivi network, Spain, 2009-2024.
Gayoso-Cantero D, Corbacho Loarte MD, Díaz-Menéndez M, Molina I, Goikoetxea Aguirre J, Torrús D, Herrero-Martínez JM, Rodríguez Guardado A, Navarrete Lorite MN, Aguirre IL, de Miguel Buckley R, Pou Ciruelo D, Aznar ML, Salvador F, Perez Molina JA, Norman FF; +Redivi Study Group. Gayoso-Cantero D, et al. Travel Med Infect Dis. 2026 Sep-Oct;73:103010. doi: 10.1016/j.tmaid.2026.103010. Epub 2026 Jul 8. Travel Med Infect Dis. 2026. PMID: 42419580 Free article.
Ivermectin Effect on In-Hospital Mortality and Need for Respiratory Support in COVID-19 Pneumonia: Propensity Score-Matched Retrospective Study.
Llenas-García J, Del Pozo A, Talaya A, Roig-Sánchez N, Poveda Ruiz N, Devesa García C, Borrajo Brunete E, González Cuello I, Lucas Dato A, Navarro M, Wikman-Jorgensen P. Llenas-García J, et al. Among authors: lucas dato a. Viruses. 2023 May 10;15(5):1138. doi: 10.3390/v15051138. Viruses. 2023. PMID: 37243224 Free PMC article.
Cytokine profile levels and their relationship with parasitemia and cardiomyopathy in people with Chagas disease in Spain. A prospective observational study.
Ramos-Rincon JM, Torrús-Tendero D, García-Morante H, Gimeno-Gascón A, Marco F, Gil-Anguita C, Wikman-Jorgensen P, Lucas-Dato A, Rodriguez-Diaz JC, Amador C, Llenas-García J. Ramos-Rincon JM, et al. Among authors: lucas dato a. Parasitol Res. 2023 Dec 22;123(1):66. doi: 10.1007/s00436-023-08042-8. Parasitol Res. 2023. PMID: 38133693 Free PMC article.
Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol.
Salvador F, Lucas-Dato A, Roure S, Arsuaga M, Pérez-Jacoiste A, García-Rodríguez M, Pérez-Molina JA, Buonfrate D, Saugar JM, Molina I. Salvador F, et al. Among authors: lucas dato a. Pathogens. 2021 Jun 27;10(7):812. doi: 10.3390/pathogens10070812. Pathogens. 2021. PMID: 34199000 Free PMC article.
12 results